WO2002007672A3 - A medicinal aerosol formulation - Google Patents
A medicinal aerosol formulation Download PDFInfo
- Publication number
- WO2002007672A3 WO2002007672A3 PCT/US2000/042625 US0042625W WO0207672A3 WO 2002007672 A3 WO2002007672 A3 WO 2002007672A3 US 0042625 W US0042625 W US 0042625W WO 0207672 A3 WO0207672 A3 WO 0207672A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aerosol formulation
- medicinal aerosol
- medicinal
- particulate
- propellant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Otolaryngology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001247123A AU2001247123A1 (en) | 2000-07-19 | 2000-12-07 | A medicinal aerosol formulation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61918300A | 2000-07-19 | 2000-07-19 | |
US09/619,183 | 2000-07-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002007672A2 WO2002007672A2 (en) | 2002-01-31 |
WO2002007672A3 true WO2002007672A3 (en) | 2002-06-27 |
Family
ID=24480789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/042625 WO2002007672A2 (en) | 2000-07-19 | 2000-12-07 | A medicinal aerosol formulation |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001247123A1 (en) |
WO (1) | WO2002007672A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
EP2319585A1 (en) | 2002-08-29 | 2011-05-11 | Cipla Ltd. | Pharmaceutical products and compositions comprising salmeterol, fluticasone and ipratropium or tiotropium |
GB0323684D0 (en) | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
CL2008000500A1 (en) | 2007-02-19 | 2008-09-05 | Cipla Ltd | PHARMACEUTICAL COMBINATION THAT INCLUDES A COMBINATION OF TWO OR MORE BRONCHODILATORS OR A COMBINATION OF AT LEAST ONE BRONCODILATATOR AND AT LEAST ONE CORTICOSTEROID; USE TO TREAT OR PREVENT A RESPIRATORY DISEASE; AND INHALER UNDERSTANDING DI |
GB0918149D0 (en) * | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved medicinal aerosol formulation |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225183A (en) * | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
US5674471A (en) * | 1991-12-12 | 1997-10-07 | Glaxo Group Limited | Aerosol formulations containing P134a and salbutamol |
US5676931A (en) * | 1993-12-02 | 1997-10-14 | Abbott Laboratories | Aerosol drug formulations for use with non CFC propellants |
US5695744A (en) * | 1992-02-06 | 1997-12-09 | Glaxo Group Limited | Medicaments |
US6136294A (en) * | 1998-09-22 | 2000-10-24 | Aeropharm Technology Inc. | Amino acid stabilized medical aerosol formulation |
-
2000
- 2000-12-07 WO PCT/US2000/042625 patent/WO2002007672A2/en active Application Filing
- 2000-12-07 AU AU2001247123A patent/AU2001247123A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225183A (en) * | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
US5674471A (en) * | 1991-12-12 | 1997-10-07 | Glaxo Group Limited | Aerosol formulations containing P134a and salbutamol |
US5695744A (en) * | 1992-02-06 | 1997-12-09 | Glaxo Group Limited | Medicaments |
US5676931A (en) * | 1993-12-02 | 1997-10-14 | Abbott Laboratories | Aerosol drug formulations for use with non CFC propellants |
US6136294A (en) * | 1998-09-22 | 2000-10-24 | Aeropharm Technology Inc. | Amino acid stabilized medical aerosol formulation |
US6136294C1 (en) * | 1998-09-22 | 2002-09-24 | Aeropharm Technology Inc | Amino acid stabilized medical aerosol formulation |
Also Published As
Publication number | Publication date |
---|---|
AU2001247123A1 (en) | 2002-02-05 |
WO2002007672A2 (en) | 2002-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1135173A4 (en) | A medicinal aerosol formulation | |
CA2416403A1 (en) | A medicinal aerosol formulation | |
US6136294C1 (en) | Amino acid stabilized medical aerosol formulation | |
CA2497171A1 (en) | Water stabilized medicinal aerosol formulation | |
WO2000041681A3 (en) | MEDICINAL FORMULATIONS CONTAINING AN OPIOID AND AN α-ANTAGONIST | |
DE60019167D1 (en) | PHARMACEUTICAL AEROSOL FORMULATION CONTAINING SALMETEROL AND FLUTICASONE | |
DE60031504D1 (en) | FLUTICASONPROPIONATE DRUG PREPARATION | |
WO2001082874A3 (en) | A medicinal aerosol formulation | |
MXPA03001752A (en) | Pharmaceutical formulation of salmeterol and fluticasone propionate. | |
WO2002007672A3 (en) | A medicinal aerosol formulation | |
WO2001082868A3 (en) | A medicinal aerosol formulation | |
WO2002000191A3 (en) | Bdellosomes | |
EP1273301A3 (en) | Pharmaceutical preparations based on active ingredients susceptible to illict administration | |
WO2001037818A3 (en) | Medicament and combination of compatible medicaments | |
AU2002212863A1 (en) | Stable pharmaceutical form of an anticancer drug | |
WO2002036105A3 (en) | Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders | |
WO2001039741A3 (en) | Mitomycin c solution | |
AU1534501A (en) | Pharmaceutical formulations of salmeterol | |
WO2002041875A3 (en) | Method for producing readily soluble medicament formulations and corresponding formulations | |
WO2001030372A3 (en) | Pharmaceutical agent preparations | |
CA2446562A1 (en) | Pharmaceutical formulation of fluticasone propionate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |